Pitch-Off Keynote Speaker: Amar Sawhney
Chairman and CEO of Instylla Inc.
Amarpreet Sawhney is the Chairman and CEO OF Instylla Inc which is developing new liquid embolics for tumor embolization and hemostasis. He is also CEO of Rejoni Inc., which is developing products to prevent adhesions following gynecological interventions.
Previously he was President and CEO of Ocular Therapeutix, Inc. (OCUL: NASDAQ) a company focused on unmet needs in ophthalmic drug delivery. He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies, which account for over 4,000 jobs created and over $2 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator.
Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.